Evans EA - Search Results

1

Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.

Evans EA, Wilson D, Friedmann PD. Evans EA, et al. Drug Alcohol Depend. 2022 Feb 1;231:109254. doi: 10.1016/j.drugalcdep.2021.109254. Epub 2022 Jan 18. Drug Alcohol Depend. 2022. PMID: 35063323 Free PMC article.

2

Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.

Nosyk B, Li L, Evans E, Urada D, Huang D, Wood E, Rawson R, Hser YI. Nosyk B, et al. Drug Alcohol Depend. 2014 Oct 1;143:149-57. doi: 10.1016/j.drugalcdep.2014.07.020. Epub 2014 Jul 27. Drug Alcohol Depend. 2014. PMID: 25110333 Free PMC article.

3

Gender differences in mortality among treated opioid dependent patients.

Evans E, Kelleghan A, Li L, Min J, Huang D, Urada D, Hser YI, Nosyk B. Evans E, et al. Drug Alcohol Depend. 2015 Oct 1;155:228-35. doi: 10.1016/j.drugalcdep.2015.07.010. Epub 2015 Jul 17. Drug Alcohol Depend. 2015. PMID: 26282107 Free PMC article.

4

Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial.

Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Zhu Y, et al. Among authors: evans ea. J Neuroimmune Pharmacol. 2018 Dec;13(4):488-497. doi: 10.1007/s11481-018-9801-x. Epub 2018 Aug 9. J Neuroimmune Pharmacol. 2018. PMID: 30094695 Free PMC article. Clinical Trial.

5

Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.

Evans EA, Zhu Y, Yoo C, Huang D, Hser YI. Evans EA, et al. Addiction. 2019 Aug;114(8):1396-1404. doi: 10.1111/add.14620. Epub 2019 May 2. Addiction. 2019. PMID: 30916463 Free PMC article. Clinical Trial.

6

Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.

Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Evans EA, et al. J Subst Abuse Treat. 2019 Nov;106:19-28. doi: 10.1016/j.jsat.2019.08.002. Epub 2019 Aug 7. J Subst Abuse Treat. 2019. PMID: 31540607 Free PMC article. Clinical Trial.

7

Editorial: COVID-19 and its impact on SUD treatment.

Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Friedmann PD, et al. J Subst Abuse Treat. 2020 Oct;117:108091. doi: 10.1016/j.jsat.2020.108091. Epub 2020 Jul 25. J Subst Abuse Treat. 2020. PMID: 32747147 Free PMC article. No abstract available.

8

Editorial: Health equity in substance use disorder treatment.

Montgomery L, Friedmann P, Abraham A, Evans E, Glass J, Ilgen M. Montgomery L, et al. J Subst Abuse Treat. 2020 Nov;118:108101. doi: 10.1016/j.jsat.2020.108101. Epub 2020 Aug 8. J Subst Abuse Treat. 2020. PMID: 32807568 No abstract available.

9

COVID-19 and treating incarcerated populations for opioid use disorder.

Donelan CJ, Hayes E, Potee RA, Schwartz L, Evans EA. Donelan CJ, et al. Among authors: evans ea. J Subst Abuse Treat. 2021 May;124:108216. doi: 10.1016/j.jsat.2020.108216. Epub 2020 Dec 2. J Subst Abuse Treat. 2021. PMID: 33288348 Free PMC article.

10

Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).

Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, Bernson D, Santelices C, McCollister KE, Hoskinson R Jr, Lincoln T, Friedmann PD; MassJCOIN Research Group. Evans EA, et al. J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8. J Subst Abuse Treat. 2021. PMID: 33483222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page